Home Cart 0 Sign in  

[ CAS No. 103285-22-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 103285-22-9
Chemical Structure| 103285-22-9
Structure of 103285-22-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 103285-22-9 ]

Related Doc. of [ 103285-22-9 ]

Alternatived Products of [ 103285-22-9 ]

Product Details of [ 103285-22-9 ]

CAS No. :103285-22-9 MDL No. :MFCD00274123
Formula : C31H32N2O8 Boiling Point : -
Linear Structure Formula :- InChI Key :MFDHAVFJDSRPKC-YXINZVNLSA-N
M.W : 560.59 Pubchem ID :11039002
Synonyms :

Calculated chemistry of [ 103285-22-9 ]

Physicochemical Properties

Num. heavy atoms : 41
Num. arom. heavy atoms : 24
Fraction Csp3 : 0.29
Num. rotatable bonds : 10
Num. H-bond acceptors : 8.0
Num. H-bond donors : 2.0
Molar Refractivity : 150.06
TPSA : 121.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.44
Log Po/w (XLOGP3) : 3.16
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 1.19
Log Po/w (SILICOS-IT) : 3.71
Consensus Log Po/w : 2.78

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.08
Solubility : 0.00467 mg/ml ; 0.00000832 mol/l
Class : Moderately soluble
Log S (Ali) : -5.38
Solubility : 0.00236 mg/ml ; 0.0000042 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.87
Solubility : 0.00000754 mg/ml ; 0.0000000135 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 5.47

Safety of [ 103285-22-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 103285-22-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 103285-22-9 ]
  • Downstream synthetic route of [ 103285-22-9 ]

[ 103285-22-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 109-88-6 ]
  • [ 173170-12-2 ]
  • [ 103285-22-9 ]
YieldReaction ConditionsOperation in experiment
64% at 100℃; 5′-O-DMT-2,2′-O-anhydrouridine (6) was prepared in two steps from uridine as previously described.37,38 The conversion to 5′-O-DMT-2′-O-methyluridine was performed in analogy to earlier reports.39,40 Magnesium methoxide was freshly prepared by heating Mg (0.5 g) in methanol (50 mL) at 60 °C for 2 h, evaporation of excess methanol and drying of the gray powder under vaccum. Dried Mg(OCH3)2 (740 mg, 8.57 mmol, 6.00 equiv) was added to a suspension of compound 6 (750 mg, 1.42 mmol, 1.00 equiv) in DMF (20 mL) and the mixture was heated to 100 °C for 2 h. A clear solution was obtained. The solvent was evaporated and the residue was taken up in ethyl acetate. The organic layer was washed with NaHCO3 and water, dried over Na2SO4 and evaporated under reduced pressure. The crude product was purified by column chromatography on SiO2 with 2–4percent methanol in DCM to give compound 7 (510 mg, 0.91 mmol, 64percent) as white solid. 1H NMR (400 MHz, CDCl3): δ (ppm)=3.54–3.57 (m, 2H, H-C(5′)), 3.65 (s, 3H, 2′-OCH3), 3.79-3.80 (m, 7H, H-C(2′), DMT-OCH3), 3.98–4.01 (m, 1H, H-C(4′)), 4.45-4.50 (m, 1H, H-C(3′)), 5.26 (d, 1H, J=8.1 Hz, H-C(5)), 5.97 (s, 1H, H-C(1′)), 6.82-6.86 (m, 4H, DMT-Har), 7.24–7.39 (m, 9H, DMT-Har), 8.03 (d, 1H, J=8.1 Hz, H-C(6)); MS (ESI): m/z =583.1 [M+Na]+.
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 20, p. 6171 - 6180
  • 2
  • [ 186581-53-3 ]
  • [ 81246-79-9 ]
  • [ 103285-22-9 ]
Reference: [1] Helvetica Chimica Acta, 1996, vol. 79, # 8, p. 2114 - 2136
[2] Russian Journal of Bioorganic Chemistry, 1996, vol. 22, # 12, p. 800 - 806
  • 3
  • [ 40615-36-9 ]
  • [ 103285-22-9 ]
Reference: [1] Patent: US5646265, 1997, A,
  • 4
  • [ 40615-36-9 ]
  • [ 2140-76-3 ]
  • [ 103285-22-9 ]
Reference: [1] Monatshefte fur Chemie, 2013, vol. 144, # 4, p. 495 - 500
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 15, p. 4539 - 4543
  • 5
  • [ 3736-77-4 ]
  • [ 103285-22-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 20, p. 6171 - 6180
  • 6
  • [ 58-96-8 ]
  • [ 103285-22-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 20, p. 6171 - 6180
Same Skeleton Products
Historical Records